These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 3308482

  • 1. Preclinical toxicology of platinum analogues in dogs.
    Lelieveld P, van der Vijgh WJ, van Velzen D.
    Eur J Cancer Clin Oncol; 1987 Aug; 23(8):1147-54. PubMed ID: 3308482
    [Abstract] [Full Text] [Related]

  • 2. Preclinical studies on toxicity, antitumour activity and pharmacokinetics of cisplatin and three recently developed derivatives.
    Lelieveld P, Van der Vijgh WJ, Veldhuizen RW, Van Velzen D, Van Putten LM, Atassi G, Danguy A.
    Eur J Cancer Clin Oncol; 1984 Aug; 20(8):1087-104. PubMed ID: 6381064
    [Abstract] [Full Text] [Related]

  • 3. Toxicology and pharmacokinetics of (1,1-bis(aminomethyl)cyclohexane)oxalatoplatinum(II) (TNO-38).
    Lelieveld P, van der Vijgh WJ, van Velzen D.
    Eur J Cancer Clin Oncol; 1986 Dec; 22(12):1467-73. PubMed ID: 3595672
    [Abstract] [Full Text] [Related]

  • 4. Ototoxicity of cisplatin vs. platinum analogs CBDCA (JM-8) and CHIP (JM-9).
    Schweitzer VG, Rarey KE, Dolan DF, Abrams G, Litterst CJ, Sheridan C.
    Otolaryngol Head Neck Surg; 1986 Apr; 94(4):458-70. PubMed ID: 3086808
    [Abstract] [Full Text] [Related]

  • 5. Comparison of intestinal toxic effects of platinum complexes: cisplatin (CDDP), carboplatin (CBDCA), and iproplatin (CHIP).
    Kralovánszky J, Prajda N, Kerpel-Fronius S, Gál F, Kiss F.
    Cancer Chemother Pharmacol; 1988 Apr; 21(1):40-4. PubMed ID: 3277733
    [Abstract] [Full Text] [Related]

  • 6. Influence of hydrolysis products of aqua(1,1-bis(aminomethyl)cyclohexane)sulfatoplatinum(II) on toxicity in rats.
    Elferink F, Van der Vijgh WJ, Van der Poort SE, Henzen-Logmans SC, Pinedo HM.
    Cancer Lett; 1984 Nov; 25(1):61-9. PubMed ID: 6542826
    [Abstract] [Full Text] [Related]

  • 7. Toxicological and tumoricidal evaluations of a new platinum complex, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato+ ++)platinum( II) monohydrate, in rats.
    Akamatsu K, Endo K, Matsumoto T, Morikawa K, Koizumi M, Koizumi K, Mitsui H.
    Jpn J Cancer Res; 1991 Jun; 82(6):724-31. PubMed ID: 1906857
    [Abstract] [Full Text] [Related]

  • 8. Vestibular morphological analysis of the effects of cisplatin vs. platinum analogs, CBDCA (JM-8) and CHIP (JM-9).
    Schweitzer VG, Rarey KE, Dolan DF, Abrams GE, Sheridan C.
    Laryngoscope; 1986 Sep; 96(9 Pt 1):959-74. PubMed ID: 3528727
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of side effects of platinum complexes (CDDP, CBDCA, CHIP) on rat bone marrow.
    Prajda N, Kralovánszky J, Gal F, Kiss F, Kerpel-Fronius S.
    In Vivo; 1989 Sep; 3(4):267-70. PubMed ID: 2519864
    [Abstract] [Full Text] [Related]

  • 10. In vivo biochemical indices of nephrotoxicity of platinum analogs tetraplatin, CHIP, and cisplatin in the Fischer 344 rat.
    Smith MA, Smith JH, Litterst CL, Copley MP, Uozumi J, Boyd MR.
    Fundam Appl Toxicol; 1988 Jan; 10(1):62-72. PubMed ID: 3350230
    [Abstract] [Full Text] [Related]

  • 11. Antitumor effects of three platinum complexes, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)-platinum (II) monohydrate (DWA2114R), cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) (CBDCA) and cis-diamminedichloroplatinum(II) (CDDP), in mice.
    Endo K, Akamatsu K, Matsumoto T, Morikawa K, Koizumi M, Mitsui H, Koizumi K.
    Anticancer Res; 1992 Jan; 12(1):49-58. PubMed ID: 1567181
    [Abstract] [Full Text] [Related]

  • 12. Comparative toxicity of cisplatin, carboplatin (CBDCA) and iproplatin (CHIP) in combination with cyclophosphamide in patients with advanced epithelial ovarian cancer.
    Anderson H, Wagstaff J, Crowther D, Swindell R, Lind MJ, McGregor J, Timms MS, Brown D, Palmer P.
    Eur J Cancer Clin Oncol; 1988 Sep; 24(9):1471-9. PubMed ID: 3053207
    [Abstract] [Full Text] [Related]

  • 13. The influence of platinum drugs on the radiation response of rat kidneys.
    van Rongen E, Kuijpers WC, Baten-Wittwer A.
    Radiother Oncol; 1994 May; 31(2):138-50. PubMed ID: 8066193
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Antitumor activity, induction of cross-resistance, and nephrotoxicity of a new platinum analogue, cis-1,1-diaminomethylcyclohexaneplatinum(II) sulfate, and of cis-diamminedichloroplatinum(II) in an immunocytoma model in the LOU/M rat.
    de Jong WH, Steerenberg PA, Vos JG, Bulten EJ, Verbeek F, Kruizinga W, Ruitenberg EJ.
    Cancer Res; 1983 Oct; 43(10):4927-34. PubMed ID: 6683993
    [Abstract] [Full Text] [Related]

  • 19. Nephrotoxicity of a novel antineoplastic platinum complex, nedaplatin: a comparative study with cisplatin in rats.
    Uehara T, Watanabe H, Itoh F, Inoue S, Koshida H, Nakamura M, Yamate J, Maruyama T.
    Arch Toxicol; 2005 Aug; 79(8):451-60. PubMed ID: 15856183
    [Abstract] [Full Text] [Related]

  • 20. Determination of platinum-containing drugs in human plasma by liquid chromatography with reductive electrochemical detection.
    Parsons PJ, Morrison PF, LeRoy AF.
    J Chromatogr; 1987 Jan 09; 385():323-35. PubMed ID: 3558589
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.